
About Pharmazell (India) Private Limited
Data last updated:
Pharmazell (India) Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 22 September 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24294TN1993PTC025852. Its GSTIN is 33AAACD3338F1Z5 (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹65 Cr and a paid-up capital of ₹10.92 Cr. It was formerly known as Diamalt Pharmorganica Private Limited and Bf Goodrich Diamalt Private Limited. It is led by directors including Anant Dattatray Barbadikar (Managing Director) and Nagarajan Karthik (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.B5 & B6 Madras Exportprocessing Zone Tambaram Madras – 600045, Chennai, Tamil Nadu, India – 600045.
As per the financials filed for FY 2025, the company reported a revenue of ₹524.65 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹54.82 Cr (net margin 10.4%) and EBITDA of ₹101.44 Cr (EBITDA margin 19.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 6% over five years.
The company has about 531 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Pharmazell Group. As per MCA filings, the company has satisfied charges of ₹15.58 Cr on record. Court records list 21 cases involving the company, including 21 filed by the company. The company has 1 deal on record (1 funding round), with disclosed funding of ₹6.42 Cr; the latest was in September 2020. Its 3 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (manufacture of chemicals and chemical products) are compared by revenue, 1 larger and 2 smaller; the largest is Raichem Medicare Private Limited with revenue of ₹515.04 Cr. The company has 15 MSME Form 1 returns on record between 2016 and 2023, listing 166 overdue payments to 55 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmazell.com.
Company details
Name history
Pharmazell (India) has undergone 2 name changes throughout its history. The company was previously known as Diamalt Pharmorganica Private Limited, and Bf Goodrich Diamalt Private Limited. The current legal name is Pharmazell (India) Private Limited.
| Company Name | Status |
|---|---|
| Pharmazell (India) Private Limited | Current |
| Diamalt Pharmorganica Private Limited | Previous |
| Bf Goodrich Diamalt Private Limited | Previous |
Contact details
Pharmazell (India) Private Limited's registered office is in Chennai, Tamil Nadu. Its website is pharmazell.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.B5 & B6 Madras Exportprocessing Zone Tambaram Madras – 600045, Chennai, Tamil Nadu, India – 600045
- IndustryPharma, API Manufacturers
To see the full contact details of Pharmazell (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Pharmazell (India) operates one associated brand: Pharmazell Group. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Active pharmaceutical ingredients are manufactured by Pharmazell Group. | pharmazell-group.com |
Business activity
The main business activity of Pharmazell (India) is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Pharmazell (India) Private Limited, buy the company report.
Financials of Pharmazell (India) Private Limited
FY 2025 filings availablePharmazell (India) Private Limited reported revenue of ₹524.65 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 3% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹524.65 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹101.44 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹54.82 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.3% | ||||
| Net Profit Margin | 10.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmazell (India) Private Limited, buy the company report.
Board of directors of Pharmazell (India) Private Limited
Pharmazell (India) has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagarajan Karthik Also directs: Pharmachol Chemicals Private Limited | Whole-Time Director | 01 Apr 2024 | 2 Years 7 Months | Current |
| Appa Rao Suryadevara | Whole-Time Director | 01 Apr 2024 | 2 Years 7 Months | Current |
| Sukumar Mani | Whole-Time Director | 01 Apr 2024 | 2 Years 7 Months | Current |
| Anant Dattatray Barbadikar | Managing Director | 19 Feb 2010 | 16 Years 8 Months | Current |
Peer comparison
Pharmazell (India) Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmazell (India) Private Limitedthis company | ₹524.65 Cr (FY 2025) | ₹54.82 Cr | 10.4% | 3.0% | 531 | Chennai, Tamil Nadu, India |
| Raichem Medicare Private Limited | ₹515.04 Cr (FY 2025) | -12.0% | Chicksugur Village, Karnataka, India | |||
| Sudarshan Pharma Industries Limited | ₹507.57 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India | |||
| Aarey Drugs and Pharmaceuticals Limited | ₹483.76 Cr (FY 2025) | 20.0% | Thane, Maharashtra, India |
To see the full peer comparison of Pharmazell (India) Private Limited, buy the company report.
Auditor
Pharmazell (India) Private Limited is audited by M S K A & Associates for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S K A & Associates | FY 2025 | 105047W |
Shareholding
The shareholding of Pharmazell (India) Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pharmazell (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Mar 2016 | 100026057 | Others | ₹15.58 Cr | Satisfied |
To see the full charge records of Pharmazell (India) Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Pharmazell (India) Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹6.42 Cr; the latest was in September 2020.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2020 | Funding round | ₹6.42 Cr | Investors: Pharmazell Gmbh, Zellbios Gmbh |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Pharmazell (India) Private Limited has 21 court cases on record: 21 filed by Pharmazell (India). All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 21 | 0 | 0 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against Assistant Commissioner of Income Tax Circle 1 and 2 others | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Ap | Disposed |
| High Court, TAMIL NADU | Appeal | Filed by the company against Assistant Commissioner of Income Tax Circle 1 and 2 others | Disposed |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against individuals | Disposed |
| High Court, TAMIL NADU | Appeal | Filed by the company against individuals | Disposed |
To see the full case history of Pharmazell (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Pharmazell (India) Private Limited has 15 MSME Form 1 returns on record between 2016 and 2023, listing 166 overdue payments to 55 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 55)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mak Clean Air Systems Private Limited | |||
| Allyone Environmental Technologies India Private Limited | |||
| Skylark Uniforms | |||
| an individual supplier | |||
| Chempharm Industries India Private Limited |
To see the full MSME payment records of Pharmazell (India) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Pharmazell (India) has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Pharmachol Chemicals Private Limited | U36100HR2016PTC058478 |
To see the full group structure of Pharmazell (India) Private Limited, buy the company report.
Employees & EPFO
Pharmazell (India) Private Limited has a workforce of 531 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 531 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Pharmazell (India) Private Limited, buy the company report.
GST
Pharmazell (India) has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACD3338F1Z5 | Tamil Nadu | Active | 01 Jul 2017 |
| 37AAACD3338F1ZX | Andhra Pradesh | Active | 17 Mar 2020 |
To see the full GST registrations and return filing status of Pharmazell (India) Private Limited, buy the company report.
Recent activity
Pharmazell (India) Private Limited has 12 board changes on record since 2010: 4 appointments and 8 cessations. The latest: Appa Rao Suryadevara ceased to be Director on 16 Apr 2024.
6 earlier events are in the company report.
Frequently asked questions
Pharmazell (India) is an active private limited company based in Chennai, Tamil Nadu, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 22 September 1993 (33+ years old) and is registered under CIN U24294TN1993PTC025852.
Pharmazell (India) has 4 current directors:
- Anant Dattatray Barbadikar - Managing Director
- Nagarajan Karthik - Whole-Time Director
- Appa Rao Suryadevara - Whole-Time Director
- Sukumar Mani - Whole-Time Director
The latest financial statements of Pharmazell (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Pharmazell (India) is 33AAACD3338F1Z5, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAACD3338F1ZX (Andhra Pradesh).
The CIN (Corporate Identification Number) of Pharmazell (India) is U24294TN1993PTC025852. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmazell (India) has 21 court cases on record: 21 filed by the company.
Pharmazell (India) was incorporated on 22 September 1993, making it 33+ years old. It is registered with the Registrar of Companies, Chennai.
Pharmazell (India) has 1 deal on record (1 funding round), with disclosed funding of ₹6.42 Cr; the latest was in September 2020.
The peers of Pharmazell (India) by revenue are Raichem Medicare Private Limited, Sudarshan Pharma Industries Limited, Aarey Drugs and Pharmaceuticals Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (manufacture of chemicals and chemical products).
Appa Rao Suryadevara ceased to be Director on 16 Apr 2024. Sukumar Mani ceased to be Director on 16 Apr 2024. Appa Rao Suryadevara was appointed as Whole-Time Director on 01 Apr 2024. Pharmazell (India) has 12 board changes on record in total.
Pharmazell (India) has 15 MSME Form 1 returns on record between 2016 and 2023, listing 166 overdue payments to 55 micro and small suppliers. The latest return was filed on 05 Dec 2023.
Pharmazell (India) can be reached through the website pharmazell.com. Its registered office is in Chennai, Tamil Nadu, India.

